D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GLUE holding history
Monte Rosa Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GLUE overviewAll 13F holders of GLUEFull Q2 2026 holdings
- Shares (Q2 2026)
- 172,053
- Value
- $4.16M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 172,053 | $4.16M | <0.1% | +105,726+159.4% | Added | Holders |
| Q1 2026 | 66,327 | $1.09M | <0.1% | −19,161−22.4% | Reduced | Holders |
| Q4 2025 | 85,488 | $1.34M | <0.1% | +35,275+70.3% | Added | Holders |
| Q3 2025 | 50,213 | $372.1K | <0.1% | +50,213 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −70,114−100.0% | Sold out | Holders |
| Q4 2024 | 70,114 | $486.6K | <0.1% | +51,823+283.3% | Added | Holders |
| Q3 2024 | 18,291 | $96.9K | <0.1% | −5,131−21.9% | Reduced | Holders |
| Q2 2024 | 23,422 | $87.6K | <0.1% | +23,422 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −24,085−100.0% | Sold out | Holders |
| Q4 2021 | 24,085 | $492.0K | <0.1% | −23,039−48.9% | Reduced | Holders |
| Q3 2021 | 47,124 | $1.05M | <0.1% | +47,124 | New | Holders |